FDA Investigates Cause of Defective Lot of Johnson & Johnson COVID-19 Vaccine

<div id=”js-article__body” itemprop=”articleBody” data-sbid=”WP-MKTW-0000219264″>

The Food and Drug Administration is investigating what caused a batch of the active ingredient in Johnson & Johnson’s COVID-19 vaccine to be discarded for failing to meet quality standards at a contract manufacturing facility, according to a person familiar with the business. The FDA may send an inspection team to assess the situation at the Baltimore plant operated by contractor Emergent BioSolutions Inc. EBS, -13.40%, the person said.